Structure | Chemical Name | CAS | MF |
|
IC BLOCK(TM) TRANSPORT INHIBITOR
|
|
|
|
IB-MECA
|
152918-18-8
|
C18H19IN6O4
|
|
I Blood-Group System
|
|
|
|
ICC FIXATION BUFFER
|
|
|
|
ICBP90 protein
|
|
|
|
ICB-1 protein
|
|
|
|
ICD-467
|
|
|
|
I-309(CCL1),HUMAN,RECOMBINANT
|
|
|
|
I-BmoI endonuclease
|
|
|
|
C. difficile Toxin B (529-536)
|
|
|
|
C. difficile Toxin B (232-241)
|
|
|
|
C. difficile Toxin B (192-207)
|
|
|
|
C. difficile Toxin B (8-16)
|
|
|
|
C. difficile Toxin B (248-262)
|
|
|
|
C. difficile Toxin B (392-401)
|
|
|
|
2-IBMT
|
|
C15H19IN2O2
|
|
ICE, ALL PRIMER
|
|
|
|
ICE (ALPHA,BETA,GAMMA) SPLICE VARIANTS PRIMER
|
|
|
|
ICE AND SNOW CONTROL SALT
|
|
|
|
ICEBERG protein
|
|
|
|
ICEBERG, HUMAN, 16AA NEAR NT
|
|
|
|
Iceberg, Human Control Peptide
|
|
|
|
ICEBERG Caspase-1 inhibitor, ~25kD, Goat anti-
|
|
|
|
ICEBERG
|
|
|
|
ICEBERG (CT) Immunizing Peptide
|
|
|
|
ICEBERGLETTUCE
|
|
|
|
iceA2 protein
|
|
|
|
iceA1 protein
|
|
|
|
ICE (Caspase-1) Suc-Tyr-Val-Ala-Asp-AMC
|
|
|
|
ICE (Caspase-1) Mca-Tyr-Val-Ala-Asp-Ala-Pro-Lys(Dnp)
|
|
|
|
ICE (CASPASE I) SUBSTRATE III 97+%
|
|
|
|
ICE (CASPASE I) SUBSTRATE 97+%
|
|
|
|
ICE BLOCK (ALUMINUM) 6"X 6", 86 PLACE
|
|
|
|
ICEBURGLETTUCE
|
|
|
|
ICE BUCKET, SQUARE, BLUE
|
|
|
|
ICE BUCKET, LARGER SIZE, BLUE
|
|
|
|
ICE BUCKET
|
|
|
|
ICE BUCKET, ROUND WITH LID, BLUE
|
|
|
|
ICEDBLACKTEA
|
|
|
|
Ice crystal printing ink
|
|
|
|
ICE-CREAM FLAVOUR (STRAWBERRY)
|
|
|
|
ICE-CREAM FLAVOUR (PEPPERMINT)
|
|
|
|
ICECREAM
|
|
|
|
ICE-CREAM FLAVOURS VANILLA LF 080.001
|
|
|
|
ICE-CREAM MIX (FOR SOFT
|
|
|
|
IBMX (3-Isobutyl-1-methylxanthine)
|
|
|
|
Iboctadekin
|
479198-61-3
|
|
|
IBOGAINE (D3, 98%) 100 UG/ML IN METHANOL
|
|
|
|
IBOGAMINE
|
481-87-8
|
|
|
(2α,5β,6α,18β)-Ibogamine-18-carboxylic acid methyl ester
|
38542-83-5
|
C21H26N2O2
|
|
(2α,5β,6α,18β)-Ibogamine
|
1673-99-0
|
|
|
ibogamine
|
|
|
|
Ibogamine-18-carboxylic acid, 12-((3alpha)-17-methoxy-17-oxovobasan-3- yl)-, methyl ester
|
80981-94-8
|
|
|
Ibogamine-18-carboxylic acid, 14-((3alpha)-17-methoxy-17-oxovobasan-3- yl)-, methyl ester
|
80981-95-9
|
|
|
IBOGAINE HYDROCHLORIDE--DEA*SCHEDULE I I TEM
|
5934-55-4
|
C20H26N2O.ClH
|
|
IBOGAINE UNLABELED 1.0 MG/ML IN METHANOL
|
|
|
|
IBOGAINE
|
83-74-9
|
C20H26N2O
|
|
IBOGAINE HYDROCHLORIDE
|
|
C20H27ClN2O
|
|
IBOGAINE [3H(G)]
|
|
|
|
IceGel Hard
|
|
|
|
IceGel Soft
|
|
|
|
[125I]-BNP-32 (RAT)
|
|
C146H238IN47O44S3
|
|
[125I]-BNP-45 (RAT)
|
|
|
|
icd protein
|
|
|
|
4-IBP
|
155798-08-6
|
C19H21IN2O
|
|
ICE INHIBITOR W-3
|
|
|
|
ICE INHIBITOR W-2
|
|
|
|
ICE INHIBITOR W-1
|
|
|
|
ICELANDICSMOKEDCUREDMUTTON
|
|
|
|
ICELANDMOSS
|
|
|
|
ICE-LAP3 protein
|
|
|
|
ICE-LAP6 protein
|
|
|
|
ICELANDICPOPPY
|
|
|
|
IbpA protein
|
|
|
|
icella Zoster Virus (VZV), anti-Glycoprotein gpI
|
|
|
|
IbpB protein
|
|
|
|
Ibopamine Hylbochloride
|
|
|
|
ice nucleation protein
|
|
|
|
ibopamine
|
66195-31-1
|
C17H25NO4
|
|
ICE NUCLEATION ACTIVE BACTERIA, CELL DEBRIS
|
|
|
|
ICE protocol 6
|
|
|
|
ICE protocol 5
|
|
|
|
ICE protocol 4
|
|
|
|
ICE protocol 3
|
|
|
|
ICE protocol 1
|
|
|
|
ICE protocol 2
|
|
|
|
Ice Protease Activating Factor (IPAF, CARD12, CLANA) (Control Peptide)
|
|
|
|
Ice Protease Activating Factor (IPAF)
|
|
|
|
Ice Protease Activating Factor, Human, Control Peptide (IPAF, CARD12)
|
|
|
|
Ice Protease Activating Factor (IPAF, CARD12, CLANA)
|
|
|
|
Ice Protease Activating Factor, Human (IPAF) Control Peptide
|
|
|
|
Ice Protease Activating Factor (IPAF) or CARD12
|
|
|
|
ICE-related protease 1
|
|
|
|
ICERE-1 proteins
|
|
|
|
icfG protein
|
|
|
|
125I-Azido-papa-apec
|
129932-69-0
|
|
|
IBOTENIC ACID(REAGENT / STANDARD GRADE)
|
|
C5H6N2O4
|
|
IBOTENIC ACID
|
2552-55-8
|
C5H6N2O4
|
|
IBOTENIC ACID MONOHYDRATE
|
60573-88-8
|
C5H8N2O5
|
|
Ibotenoicacid
|
|
C5H6N2O4
|